Suchergebnisse - "van der Heijde, Désirée"

PubPharm (147)

1

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND) : 3-year results from an open-label, randomised controlled, non-inferiority trial

enthalten in: The Lancet. Rheumatology | 2024

von Kjørholt, K. | Sundlisæter, N. | Aga, A. | +19

2

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2022

von Deodhar, A. | Van den Bosch, F. | Poddubnyy, D. | +10

CommentIn: Lancet. 2022 Jul 30;400(10349):340-341. - PMID 35908562

3

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

enthalten in: Arthritis care & research | 2022

von Walsh, J. | Magrey, M. | Baraliakos, X. | +14

4

Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years : Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von McInnes, I. | Rahman, P. | Gottlieb, A. | +9

5

Effects of Denosumab in Japanese Patients With Rheumatoid Arthritis Treated With Conventional Antirheumatic Drugs : 36-month Extension of a Phase III Study

enthalten in: The Journal of rheumatology | 2021

von Tanaka, Y. | Takeuchi, T. | Soen, S. | +7

6

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis

enthalten in: The Journal of rheumatology | 2021

von Taylor, P. | van der Heijde, D. | Landewé, R. | +3

7

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate : a phase III randomised clinical trial

enthalten in: Annals of the rheumatic diseases | 2021

von Combe, B. | Kivitz, A. | Tanaka, Y. | +17

8

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate : the phase 3, randomised controlled FINCH 3 trial

enthalten in: Annals of the rheumatic diseases | 2021

von Westhovens, R. | Rigby, W. | van der Heijde, D. | +16

9

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission : The ARCTIC REWIND Randomized Clinical Trial

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +18

CommentIn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

10

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable

enthalten in: Rheumatology (Oxford, England) | 2021

von Ortolan, A. | Ramiro, S. | van Gaalen, F. | +7

CommentIn: Rheumatology (Oxford). 2021 Feb 1;60(2):e71-e72. - PMID 33244592

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]